One Year Subscription to Protein Target & Pipeline Database

News provided by

Research and Markets

07 Mar, 2014, 12:19 GMT

DUBLIN, Mar. 07, 2014
/PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/jsml5t/protein_target) has announced the addition of the "One Year Subscription to Protein Target & Pipeline Database" subscription to their offering.

(Logo:http://photos.prnewswire.com/prnh/20130307/600769)

Subscription to La Merie Publishing's proprietary Protein Database provides online access to information about more than 1900 project entries for therapeutic proteins on the market and in research & development. Pre-established and free search functions allow to identify proteins according to their:

  • Target (e.g. Factor VIII, G-CSF, FSH)
  • Pipelines (selected by target, therapeutic area, company)
  • Sales (for marketed proteins)
  • R&D Phase (clinical phases, market, preclinical)
  • Territory (countrywise)
  • Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
  • Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic proteins is intuitive.

By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database:

  • Biosimilar and Biosuperior Proteins

Prerequisite: Internet access

Purchase of the subscription provides a 1-year online access to the data of the Protein Target & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the Protein Target & Pipeline Database:

  • Intuitive use
  • Designed for structured searches
  • Focused on targets, therapeutic areas and R&D phases
  • Ideal for competitor analysis (companies, targets, technologies, R&D phase)
  • Cost-effective and rapid solution for benchmarking
  • Identification of licensing candidates

Project listing in a tabular format:

  • Drug Codes
  • Target
  • Class of Compound
  • Company
  • Territory
  • Therapeutic Area
  • Indication
  • R&D Phase

Therapeutic Areas:

  • Cardiovascular & blood
  • Dermatology
  • Gastrointestinal
  • Genitourinary, renal & gynecology
  • Infectious & toxicology
  • Metabolism & endocrine
  • Neurology & psychiatry
  • Oncology
  • Ophthalmology & otorhinolaryngology
  • Orthopedics, dental, anesthesia & surgery
  • Pulmonary & respiratory
  • Rheumatoid & autoimmune

Predefined Targets of the Scroll Down Menu examples:

  • Coagulation Factors
  • Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA)
  • G-CSF & GM-CSF
  • Thrombopoietin (TPO) & Thrombopoiesis Stimulating Agents
  • Interferon
  • Insulin
  • Human Growth Hormone (hGH)
  • FSH, LH & hCG (Assisted Reproduction Technology: ART)
  • Thrombolytics & Fibrinolytics
  • Enzyme Replacement Therapies (ERT)
  • Growth Factors (e.g. FGF, PDGF, EGF, VEGF, TGF, NGF)


For more information visit http://www.researchandmarkets.com/research/jsml5t/protein_target

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net